Advertisement

Table of Contents

January 10, 2019; 133 (2)

BLOOD COMMENTARIES

  • BID-ding on necroptosis in MDS
    Ben A. Croker and Michelle A. Kelliher
  • Resolved HBV and anti-CD20 therapy
    Lisa K. Hicks and Jordan J. Feld

PLENARY PAPER

PERSPECTIVE

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

LYMPHOID NEOPLASIA

  • IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
    IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
    Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, Nicoletta Vitale, Elisabetta Mereu, Cecilia Bandini, Elisa Pellegrino, Verdiana Pullano, Paola Omedè, Katia Todoerti, Luciano Cascione, Valentina Audrito, Anna Riccio, Antonio Rossi, Francesco Bertoni, Silvia Deaglio, Antonino Neri, Antonio Palumbo and Roberto Piva

MYELOID NEOPLASIA

BLOOD WORK